- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Cefuroxime – November 2015
Cefuroxime: oral suspension, 125 mg per 5 mL, 100 mL; tablets, 250 mg, 20, Zinnat®
Last updated
4 March 2016